Actively Recruiting
Compliance and Tolerance to Oral AntiBiotherapy in Osteoarticular Infections (OTABIO)
Led by Hospices Civils de Lyon · Updated on 2025-02-13
60
Participants Needed
1
Research Sites
115 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Bone and joint infections (BJI) are most often bacterial infections that can occur after surgery or de novo. They are rarely fatal in the short term, but are associated with significant morbidity, impaired quality of life and significant costs. Treatment of BJI is based on antibiotic therapy, often combined with surgery. Antibiotic therapy, at high doses, lasts a minimum of 6 weeks. It can be responsible for severe adverse effects. These characteristics (prolonged duration, multiple daily doses, and adverse effects) are known to negatively affect treatment adherence in general.
CONDITIONS
Official Title
Compliance and Tolerance to Oral AntiBiotherapy in Osteoarticular Infections (OTABIO)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years or older
- Diagnosis of osteoarticular infection
- Receiving at least one oral antibiotic treatment expected to last 6 weeks or more with a known end date
- Informed about the study and did not object to participate
You will not qualify if you...
- Receiving oral antibiotic treatment for BJI without a known end date
- Receiving only parenteral antibiotic treatment for BJI
- No telephone number or unwilling to provide one
- Adults under legal protection measures
- Pregnant or breastfeeding women
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hospices Civils de Lyon
Lyon, France, 69004
Actively Recruiting
Research Team
T
Tristan FERRY, MD, PHD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here